Fate Therapeutics, Inc. (FATE) Stock Price

4.13 ▼ -0.02 (-0.48%)
Open: 4.26 Vol: 1.04M Day's range: 4.13 - 4.54 Dec 11, 15:54 EST
IEX Real-Time Price
Loading chart ...
FATE Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 4.20▼ 4.29▼ 4.34▼ 4.09▲ 4.24▼
MA10 4.34▼ 4.40▼ 4.30▼ 4.22▼ 4.32▼
MA20 4.42▼ 4.31▼ 4.21▼ 4.23▼ 3.97▲
MA50 4.30▼ 4.22▼ 4.26▼ 4.29▼ 3.79▲
MA100 4.24▼ 4.27▼ 4.26▼ 3.86▲ 3.01▲
MA200 4.29▼ 4.36▼ 4.38▼ 3.88▲ 4.39▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.053▼ -0.027▼ 0.002▲ -0.026▼ -0.006▼
RSI 28.439▼ 40.683▼ 43.945▼ 45.603▼ 53.082▲
STOCH 0.000▼ 45.940     57.906     31.403     48.614    
WILL %R -100.000▼ -100.000▼ -100.000▼ -59.420     -58.000    
CCI -125.023▼ -101.343▼ -92.939     9.264     14.483    
Latest Filters Detected On FATE
GAP $FATE Open Gap Up %2 Set Alert
Fate Therapeutics, Inc. News
Monday, December 11, 2017 01:57 PM
SAN DIEGO, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today ...
Monday, December 11, 2017 03:28 AM
Claim your 2-week free trial to StreetInsider Premium here. Fate Therapeutics, Inc. (NASDAQ: FATE) announced today the generation of chimeric antigen receptor (CAR)-targeted CD8αβ+ T cells from a clonal engineered master pluripotent cell line (MPCL).
Friday, December 08, 2017 03:18 PM
SAN DIEGO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that the ...
FATE historical stock data
date open high low close volume
11/12/17 4.26 4.54 4.13 4.13 1,035,058
08/12/17 4.21 4.27 4.15 4.15 377,064
07/12/17 3.98 4.285 3.97 4.18 258,519
06/12/17 4.05 4.05 3.85 3.90 155,360
05/12/17 4.22 4.28 4.08 4.08 117,481
04/12/17 4.46 4.46 4.26 4.27 73,688
01/12/17 4.39 4.39 4.23 4.39 96,444
30/11/17 4.40 4.41 4.39 4.39 89,237
29/11/17 4.35 4.43 4.35 4.37 100,974
28/11/17 4.25 4.41 4.25 4.30 139,329
Quote Details
Bid:4.13
Ask:4.69
52wk Low:2.40
52wk High:5.25
Vol:1.04M
Avg Vol(3m):3.7M
1Y Chng:+50.18%
1M Chng:-9.03%
Add to Watch List